Market by Product, Application, End-user, and Country | Forecast 2019-2028
Triton Market Research has concluded that the North America neurorehabilitation device market is projected to grow at a CAGR of 14.56% in the estimated years 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries reviewed in this market are:
• United States
• Canada
The
neurorehabilitation device market in the United States is being driven mainly
by the rising geriatric population. The people in this age group are highly
prone to developing neurological diseases. This is leading to a rise in the
cases of Alzheimer's and Parkinson's disease in the country.
According
to the Alzheimer's Association, close to 5.8 million people in the US aged 65 and
older are reported to be living with Alzheimer's dementia at present. It
further states that one in every three adults in the country loses their life
to Alzheimer's or other dementia. Further, every 65 seconds, someone in the
country is impacted by AD. Also, around one in ten persons aged over 65 years
is found to be affected by the disease.
As
per the Parkinson's Foundation Prevalence Project, around 930,000 people in the
US are affected by PD at present. This number is estimated to rise to 1.2
million people by the year 2030. Thus, the rising prevalence of neurological
diseases is paving the way for the adoption of neurorehabilitation devices.
This is expected to aid in the growth of the neurorehabilitation device market
in the United States.
Further,
government institutions are also working on the development and innovation of
therapeutics and diagnostics for Alzheimer's disease. For instance, the
National Institute of Health allocated funds worth $589 million on research
projects for AD. This is further helping the growth of the studied market in
the years to come.
Helius
Medical Technologies is engaged in developing, designing, manufacturing, and
commercializing products for treating neurological symptoms caused by disease
or trauma. The company is actively involved in developing portable
neuromodulation stimulators or PoNs, which is a device for treating movement,
gait, and balance disorders in patients with traumatic brain injury (TBI) and
other chronic neurological diseases. Founded in the 1990s, Helius Medical is
headquartered in Newtown, Pennsylvania, the United States.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA NEUROREHABILITATION DEVICE
MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. COMPETITIVE
RIVALRY
2.3. SUPPLY
CHAIN OUTLOOK
2.4. IMPACT
OF CORONAVIRUS ON NEUROREHABILITATION DEVICE MARKET
2.5. ETYMOLOGY
OF NEUROREHABILITATION DEVICE
2.6. KEY
IMPACT ANALYSIS
2.7. MARKET
ATTRACTIVENESS INDEX
2.8. KEY
INSIGHTS
2.9. MARKET
DRIVERS
2.9.1. RISE
IN GERIATRIC POPULATION
2.9.2. GROWING
EMERGENCE OF NEUROREHABILITATION WEARABLES AND ROBOTICS
2.9.3. RISING
PREVALENCE OF NEUROLOGICAL DISEASES
2.10.MARKET RESTRAINTS
2.10.1. LACK OF OF SKILLED WORKFORCE TO TREAT AND
MANAGE NEUROLOGICAL DISEASES
2.10.2. HIGH COST OF TREATMENT
2.11.MARKET OPPORTUNITIES
2.11.1. ADVANCEMENTS IN TECHNOLOGY
2.11.2. RISING INCIDENCE OF NEUROLOGICAL DISORDERS IN
DEVELOPING ECONOMIES
2.12.MARKET CHALLENGES
2.12.1. STRINGENT GOVERNMENT REGULATIONS
3. NEUREHABILITATION
MARKET OUTLOOK - BY PRODUCT
3.1. NEURO-ROBOTIC
SYSTEM
3.2. BRAIN-COMPUTER
INTERFACE
3.3. WEARABLE
DEVICE
3.4. NON-INVASIVE
STIMULATOR
3.5. OTHER
PRODUCTS
4. NEUREHABILITATION
MARKET OUTLOOK - BY APPLICATION
4.1. STROKE
4.2. CEREBRAL
PALSY
4.3. PARKINSON’S
DISEASE
4.4. MULTIPLE
SCLEROSIS
4.5. OTHER
APPLICATIONS
5. NEUREHABILITATION
MARKET OUTLOOK - BY END-USER
5.1. HOSPITAL/CLINIC
5.2. RESEARCH
INSTITUTE
5.3. COGNITIVE
CARE CENTER
5.4. OTHER
END-USER
6. NEUREHABILITATION
MARKET – NORTH AMERICA
6.1. COUNTRY
ANALYSIS
6.1.1. UNITED
STATES
6.1.2. CANADA
7. COMPANY
PROFILES
7.1. BIONIK
LABORATORIES CORP
7.2. TYROMOTION
GMBH
7.3. BIOXTREME
7.4. ECTRON
LIMITED
7.5. KINOVA
7.6. ABBOTT
LABORATORIES
7.7. BIOMETRICS
LTD
7.8. REHA
TECHNOLOGY AG
7.9. MEDTRONIC
INC
7.10.HELIUS MEDICAL TECHNOLOGIES
7.11.HOKOMA AG
7.12.KINESTICA
7.13.SAEBO
7.14. NEUROSTYLE PTE LTD
7.15. EKSO BIONICS HOLDINGS INC
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1 NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY COUNTRY,
2019-2028 (IN $ MILLION)
TABLE 2 NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY PRODUCT,
2019-2028 (IN $ MILLION)
TABLE 3 NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY
APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 4 NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY END-USER,
2019-2028 (IN $ MILLION)
TABLE 5 NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY COUNTRY,
2019-2028 (IN $ MILLION)
FIGURE 1 NORTH AMERICA NEUROREHABILITATION DEVICE
MARKET 2019-2028 (IN $ MILLION)
FIGURE 2 SUPPLY CHAIN OUTLOOK FOR
NEUROREHABILITATION DEVICE MARKET
FIGURE 3 ETYMOLOGY OF NEUROREHABILITATION DEVICE MARKET
FIGURE 4 PREVALENCE OF ALZHEIMER’S DISEASE IN THE
UNITED STATES, AGE WISE, 2019 (%)
FIGURE 5 NUMBER OF GERIATRIC POPULATION (IN MILLION)
FIGURE 6 NORTH AMERICA NEUROREHABILITATION DEVICE
MARKET, BY NEURO-ROBOTIC SYSTEM, 2019-2028 (IN $ MILLION)
FIGURE 7 NORTH AMERICA NEUROREHABILITATION DEVICE
MARKET, BY BRAIN-COMPUTER INTERFACE, 2019-2028 (IN $ MILLION)
FIGURE 8 NORTH AMERICA NEUROREHABILITATION DEVICE
MARKET, BY WEARABLE DEVICE, 2019-2028 (IN $ MILLION)
FIGURE 9 NORTH AMERICA NEUROREHABILITATION DEVICE
MARKET, BY NON-INVASIVE STIMULATOR, 2019-2028 (IN $ MILLION)
FIGURE 10 NORTH AMERICA NEUROREHABILITATION DEVICE
MARKET, BY OTHER PRODUCTS, 2019-2028 (IN $ MILLION)
FIGURE 11 NORTH AMERICA NEUROREHABILITATION DEVICE
MARKET, BY STROKE, 2019-2028 (IN $ MILLION)
FIGURE 12 NORTH AMERICA NEUROREHABILITATION DEVICE
MARKET, BY CEREBRAL PALSY, 2019-2028 (IN $ MILLION)
FIGURE 13 NORTH AMERICA NEUROREHABILITATION DEVICE
MARKET, BY PARKINSON’S DISEASE, 2019-2028 (IN $ MILLION)
FIGURE 14 NORTH AMERICA NEUROREHABILITATION DEVICE
MARKET, BY MULTIPLE SCLEROSIS, 2019-2028 (IN $ MILLION)
FIGURE 15 NORTH AMERICA NEUROREHABILITATION DEVICE
MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ MILLION)
FIGURE 16 NORTH AMERICA NEUROREHABILITATION DEVICE
MARKET, BY HOSPITAL/CLINIC, 2019-2028 (IN $ MILLION)
FIGURE 17 NORTH AMERICA NEUROREHABILITATION DEVICE
MARKET, BY RESEARCH INSTITUTE, 2019-2028 (IN $ MILLION)
FIGURE 18 NORTH AMERICA NEUROREHABILITATION DEVICE
MARKET, BY COGNITIVE CARE CENTER, 2019-2028 (IN $ MILLION)
FIGURE 19 NORTH AMERICA NEUROREHABILITATION DEVICE
MARKET, BY OTHER END-USER, 2019-2028 (IN $ MILLION)
FIGURE 20 UNITED STATES NEUROREHABILITATION DEVICE
MARKET 2019-2028 (IN $ MILLION)
FIGURE 21 CANADA NEUROREHABILITATION DEVICE MARKET 2019-2028 (IN $ MILLION)